Tamoxifen ecotoxicity and resulting risks for aquatic ecosystems

Chemosphere

Volumn 128, Issue , 2015, Pages 79-84

  Orias, Frédéric ^a   Bony, Sylvie ^a   Devaux, Alain ^a   Durrieu, Claude ^a   Aubrat, Marion ^a   Hombert, Thibault ^a   Wigh, Adriana ^a   Perrodin, Yves ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Aquatic ecosystems; Ecotoxicity; Ecotoxicological risk assessment; Tamoxifen; Trophic level

Indexed keywords

CELL PROLIFERATION; RISK ASSESSMENT; SURFACE WATERS;

CHLAMYDOMONAS REINHARDTII; ECOTOXICITY; ECOTOXICOLOGICAL RISK ASSESSMENT; ECOTOXICOLOGICAL RISKS; NO EFFECT CONCENTRATION; PSEUDOKIRCHNERIELLA SUBCAPITATA; TAMOXIFEN; TROPHIC LEVEL;

AQUATIC ECOSYSTEMS;

TAMOXIFEN; WATER; ANTIESTROGEN; WATER POLLUTANT;

ALGA; AQUATIC ECOSYSTEM; CANCER; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; PRIMARY PRODUCTION; RISK ASSESSMENT;

AQUATIC ENVIRONMENT; ARTICLE; BIOASSAY; CHLAMYDOMONAS REINHARDTII; CHLORELLA VULGARIS; CONSUMER; DAPHNIA MAGNA; ECOTOXICITY; IMMOBILIZATION; NONHUMAN; REPRODUCTION; RISK; SELENASTRUM CAPRICORNUTUM; ZEBRA FISH; ANIMAL; DAPHNIA; DRUG EFFECTS; ECOSYSTEM; ECOSYSTEM MONITORING; ECOTOXICOLOGY; GREEN ALGA; METABOLISM; TOXICITY; WATER POLLUTANT;

CHLAMYDOMONAS REINHARDTII; CHLORELLA VULGARIS; DANIO RERIO; DAPHNIA MAGNA; SELENASTRUM CAPRICORNUTUM;

ANIMALS; CHLORELLA VULGARIS; CHLOROPHYTA; DAPHNIA; ECOLOGICAL PARAMETER MONITORING; ECOSYSTEM; ECOTOXICOLOGY; ESTROGEN ANTAGONISTS; TAMOXIFEN; WATER POLLUTANTS, CHEMICAL; ZEBRAFISH;

EID: 84925269208     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2015.01.002     Document Type: Article

References (40)

1. AFNOR, 1980. Détermination de l'inhibition de la croissance de Scenedesmus subspicatus par une substance.
2. Bengtsson G., Hansson L.-A., Montenegro K. Reduced grazing rates in Daphnia pulex caused by contaminants: Implications for trophic cascades. Environ. Toxicol. Chem. 2004, 23:2641-2648.
3. Clément B., Zaid S. A new protocol to measure the effects of toxicants on daphnid-algae interactions. Chemosphere 2004, 55:1429-1438.
4. Coetsier C.M., Spinelli S., Lin L., Roig B., Touraud E. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?. Environ. Int. 2009, 35:787-792.
5. Collado N., Rodriguez-Mozaz S., Gros M., Rubirola A., Barceló D., Comas J., Rodriguez-Roda I., Buttiglieri G. Pharmaceuticals occurrence in a WWTP with significant industrial contribution and its input into the river system. Environ. Pollut. 2014, 185:202-212.
6. Della Greca M., Iesce M.R., Isidori M., Nardelli A., Previtera L., Rubino M. Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. Chemosphere 2007, 67:1933-1939.
7. Elendt B.P., Bias W.R. Trace nutrient deficiency in Daphnia magna cultured in standard medium for toxicity testing. Effects of the optimization of culture conditions on life history parameters of D. magna. Water Res. 1990, 24:1157-1167.
8. European Chemical Bureau (ECB), I. I. 2003. Technical Guidance Document (TGD) in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market.
9. Gauld D.T. The grazing rate of planktonic copepods. J. Mar. Biol. Assoc. U. K. 1951, 29:695-706.
10. Gibs J., Stackelberg P.E., Furlong E.T., Meyer M., Zaugg S.D., Lippincott R.L. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007, 373:240-249.
11. Gorman D.S., Levine R.P. Cytochrome f and plastocyanin: their sequence in the photosynthetic electron transport chain of Chlamydomonas reinhardi. Proc. Natl. Acad. Sci. 1965, 54:1665-1669.
12. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-393.
13. Heath E., Kosjek T., Farre M., Quintana J.B., de Alencastro L.F., Castiglioni S., Gans O., Langford K., Loos R., Radjenović J., Rocca L.M., Budzinski H., Tsipi D., Petrovic M., Barcelo D. Second interlaboratory exercise on non-steroidal anti-inflammatory drug analysis in environmental aqueous samples. Talanta 2010, 81:1189-1196.
14. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
15. ISO, 1995. Qualité de l'eau - Détermination de la mobilité de Daphnia magna Straus, Cladocera, Crustacea, essai de toxicité aiguë.
16. Jean J., Perrodin Y., Pivot C., Trepo D., Perraud M., Droguet J., Tissot-Guerraz F., Locher F. Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. J. Environ. Manage. 2012, 103:113-121.
17. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
18. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J. Environ. Manage. 2009, 90:2354-2366.
19. Lajeunesse A., Gagnon C., Gagné F., Louis S., Čejka P., Sauvé S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment - evidence of biological effects. Chemosphere 2011, 83:564-571.
20. Lalumera G.M., Calamari D., Galli P., Castiglioni S., Crosa G., Fanelli R. Preliminary investigation on the environmental occurrence and effects of antibiotics used in aquaculture in Italy. Chemosphere 2004, 54:661-668.
21. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ. Int. 2009, 35:766-770.
22. Larsson D.G.J., de Pedro C., Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148:751-755.
23. Loos R., Locoro G., Comero S., Contini S., Schwesig D., Werres F., Balsaa P., Gans O., Weiss S., Blaha L., Bolchi M., Gawlik B.M. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res. 2010, 44:4115-4126.
24. López-Serna R., Petrović M., Barceló D. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci. Total Environ. 2012.
25. Mater N., Geret F., Castillo L., Faucet-Marquis V., Albasi C., Pfohl-Leszkowicz A. In vitro tests aiding ecological risk assessment of ciprofloxacin, tamoxifen and cyclophosphamide in range of concentrations released in hospital wastewater and surface water. Environ. Int. 2014, 63:191-200.
26. OECD, 1998. OECD GUIDELINES FOR TESTING OF CHEMICALS: Daphnia magna Reproduction Test.
27. OECD, 2006. OECD GUIDELINES FOR THE TESTING OF CHEMICALS: Freshwater Alga and Cyanobacteria, Growth Inhibition Test.
28. OECD, 2013. OECD GUIDELINES FOR TESTING OF CHEMICALS: Fish Embryo Acute Toxicity (FET) Test.
29. Pagano G., de Biase A., Deeva I.B., Degan P., Doronin Y.K., Iaccarino M., Oral R., Trieff N.M., Warnau M., Korkina L.G. The role of oxidative stress in developmental and reproductive toxicity of tamoxifen. Life Sci. 2001, 68:1735-1749.
30. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
31. Silva B.F.d., Jelic A., López-Serna R., Mozeto A.A., Petrovic M., Barceló D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
32. Sun L., Zha J., Spear P.A., Wang Z. Tamoxifen effects on the early life stages and reproduction of Japanese medaka (Oryzias latipes). Environ. Toxicol. Pharmacol. 2007, 24:23-29.
33. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
34. US EPA database. ; last access 01/03/14. http://www.epa.gov/ecotox/.
35. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389:416-428.
36. Williams T.D., Caunter J.E., Lillicrap A.D., Hutchinson T.H., Gillings E.G., Duffell S. Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales Promelas). Environ. Toxicol. Chem. 2007, 26:695-707.
37. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J.L. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J. Hazard. Mater. 2011, 190:588-596.
38. Zenker A., Cicero M.R., Prestinaci F., Bottoni P., Carere M. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment. J. Environ. Manage. 2014, 133:378-387.
39. Zhang J., Chang V.W.C., Giannis A., Wang J.-Y. Removal of cytostatic drugs from aquatic environment: a review. Sci. Total Environ. 2013, 445-446:281-298.
40. Zhou J.L., Zhang Z.L., Banks E., Grover D., Jiang J.Q. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J. Hazard. Mater. 2009, 166:655-661.